National Institutes of Health: Management of HIV-Related Lung Disease and Cardiovascular Co-Morbidity Grant (R34)

This grant by the National Institutes of Health aims to support clinical trials planning for robust Phase II and III clinical trials in HIV-infected populations with lung disease or cardiovascular co-morbidity. The focus is on developing intervention strategies to reduce morbidity and mortality in individuals with HIV-related lung disease and cardiovascular conditions. Applicants are expected to conduct preliminary studies critical for trial design and protocol development. Closing date for applications is March 15, 2012.

Opportunity ID: 131095

Apply

General Information

Document Type::	Grants Notice
Funding Opportunity Number::	RFA-HL-12-034
Funding Opportunity Title::	Management of HIV-Related Lung Disease and Cardiovascular Co-Morbidity (R34)
Opportunity Category::	Discretionary
Opportunity Category Explanation::
Funding Instrument Type::
Category of Funding Activity::	Health
Category Explanation::
Expected Number of Awards::
Assistance Listings Number(s)::	93.838 — Lung Diseases Research
Cost Sharing or Matching Requirement::	No
Version::	Synopsis 1
Posted Date::	Nov 17, 2011
Last Updated Date::
Original Closing Date for Applications::	Mar 15, 2012
Current Closing Date for Applications::	Mar 15, 2012
Archive Date::	Apr 15, 2012
Estimated Total Program Funding::	$ 2,000,000
Award Ceiling::	$400,000
Award Floor::	$

Eligibility

Eligible Applicants::

Native American tribal governments (Federally recognized)

Additional Information on Eligibility::

Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name::	National Institutes of Health
Description::	This FOA invites clinical trials planning grant (R34) applications to support the initial organization, protocol development, and necessary preliminary studies critical for the design of robust Phase II and III clinical trials in HIV-infected populations with lung disease alone or with cardiovascular co-morbidity. The focus of the clinical trials designed in this program will be on optimizing intervention strategies for HIV-related lung disease, with or without co-morbid cardiovascular disease, to reduce morbidity and mortality associated with these conditions.
Link to Additional Information::
Grantor Contact Information::	If you have difficulty accessing the full announcement electronically, please contact:

Version History

Version	Modification Description	Updated Date
Synopsis 1

Package Status

Below are CLOSED Opportunity Package(s) no longer available for this Funding Opportunity:

Package No: 1

Assistance Listings:	93.838
Competition ID:	ADOBE-FORMS-B2
Competition Title:	ADOBE-FORMS-B2
Opportunity Package ID:	PKG00085910
Opening Date:	Feb 15, 2012
Closing Date:	Mar 15, 2012
Agency Contact Information::	Grants Info
Who Can Apply::	Organization Applicants
mendatory_forms	SF424 (R & R) [V1.2] Project/Performance Site Location(s) [V1.4] Research And Related Other Project Information [V1.3] Research And Related Senior/Key Person Profile (Expanded) [V1.2] PHS 398 Cover Page Supplement [V1.4] PHS 398 Research Plan [V1.3] PHS 398 Checklist [V1.3]
optional_forms	R & R Subaward Budget Attachment(s) Form 5 YR 30 ATT [V1.2] PHS 398 Modular Budget [V1.2] Research & Related Budget [V1.1] PHS Cover Letter [V1.2]